Author:
Griesinger F.,Overbeck T.,Niederle N.
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Ebi N, Kubota K, Nishiwaki Y et al. (1997) Second-line chemotherapy for relapsed small cell lung cancer. Jpn J Clin Oncol 27:166–169
2. Schuette W (2001) Chemotherapy as treatment of primary and recurrent small cell lung cancer. Lung Cancer 33:S99–107
3. Ardizzoni A, Hansen H, Dombernowsky P et al. (1997) Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group. J Clin Oncol 15:2090–2096
4. von Pawel J, Schiller JH, Shepherd FA et al. (1999) Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol 17:658–667
5. Shepherd FA, Evans WK, MacCormick R, Feld R, Yau JC (1987) Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer. Cancer Treat Rep 71:941–944
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献